381 related articles for article (PubMed ID: 23142561)
1. Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients.
Zeevi A; Lunz J; Feingold B; Shullo M; Bermudez C; Teuteberg J; Webber S
J Heart Lung Transplant; 2013 Jan; 32(1):98-105. PubMed ID: 23142561
[TBL] [Abstract][Full Text] [Related]
2. Comparison Between Total IgG, C1q, and C3d Single Antigen Bead Assays in Detecting Class I Complement-Binding Anti-HLA Antibodies.
Moreno Gonzales MA; Mitema DG; Smith BH; Schinstock CA; Stegall MD; Wakefield LL; Henderson NA; DeGoey SR; Kreuter JD; Gandhi MJ
Transplant Proc; 2017 Nov; 49(9):2031-2035. PubMed ID: 29149956
[TBL] [Abstract][Full Text] [Related]
3. Technical Limitations of the C1q Single-Antigen Bead Assay to Detect Complement Binding HLA-Specific Antibodies.
Taylor CJ; Kosmoliaptsis V; Martin J; Knighton G; Mallon D; Bradley JA; Peacock S
Transplantation; 2017 Jun; 101(6):1206-1214. PubMed ID: 27306532
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of complement-dependent lymphocytotoxicity crossmatch and flow cytometry crossmatch results versus Luminex single-antigen bead-based donor-specific IgG class I antibody MFI values in live related renal transplant cases; a retrospective observation in 102 cases.
Pandey P; Pande A; Kumar Devra A; Kumar Sinha V; Prasad Bhatt A
J Immunoassay Immunochem; 2021 May; 42(3):300-313. PubMed ID: 33356865
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?
Crespo M; Torio A; Mas V; Redondo D; Pérez-Sáez MJ; Mir M; Faura A; Guerra R; Montes-Ares O; Checa MD; Pascual J
Transpl Immunol; 2013 Dec; 29(1-4):28-33. PubMed ID: 23907088
[TBL] [Abstract][Full Text] [Related]
6. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
7. Epitope Analysis Aids in Transplant Decision Making by Determining the Clinical Relevance of Apparent Pre-Transplant Donor Specific Antibodies (DSA).
Pandey S; Harville TO
Ann Clin Lab Sci; 2019 Jan; 49(1):50-56. PubMed ID: 30814077
[TBL] [Abstract][Full Text] [Related]
8. Role of Pretransplant Complement-fixing Donor-specific Antibodies Identified by C1q Assay in Kidney Transplantation.
Thammanichanond D; Wiwattanathum P; Mongkolsuk T; Kantachuvesiri S; Worawichawong S; Vallipakorn SA; Kitpoka P
Transplant Proc; 2016 Apr; 48(3):756-60. PubMed ID: 27234729
[TBL] [Abstract][Full Text] [Related]
9. Significance of Luminex-based single antigen class II bead assay and its mean fluorescence intensity in renal transplant cases; a retrospective observation in 97 cases.
Pande A; Pandey P; Kumar Devra A; Kumar Sinha V; Prasad Bhatt A
J Immunoassay Immunochem; 2020 May; 41(3):322-336. PubMed ID: 32122239
[TBL] [Abstract][Full Text] [Related]
10. Impact of C1q fixing donor-specific antibodies on renal transplant outcome.
Baranwal AK; Goswami S; Agarwal SK; Kaur G; Mehra NK
Scand J Immunol; 2021 Jul; 94(1):e13048. PubMed ID: 33914934
[TBL] [Abstract][Full Text] [Related]
11. C1q-fixing human leukocyte antigen assay in immunized renal patients: correlation between Luminex SAB-C1q and SAB-IgG.
Llorente S; Boix F; Eguia J; López M; Bosch A; Martinez H; Gonzalez MJ; López-Hernández R; Salgado G; Moya-Quiles MR; Campillo JA; García-Alonso AM; Minguela A; Jimeno L; Alvarez-López MR; Muro M
Transplant Proc; 2012 Nov; 44(9):2535-7. PubMed ID: 23146446
[TBL] [Abstract][Full Text] [Related]
12. Effect of pretransplant human leukocyte antigen antibodies detected by solid-phase assay on heart transplant outcomes.
Gandhi MJ; DeGoey SR; Bundy K; Kremers WK; Knauer R; Pereira N; Edwards B; Kushwaha S; Daly RC
Transplant Proc; 2011 Dec; 43(10):3840-6. PubMed ID: 22172857
[TBL] [Abstract][Full Text] [Related]
13. Determining donor-specific antibody C1q-binding ability improves the prediction of antibody-mediated rejection in human leucocyte antigen-incompatible kidney transplantation.
Malheiro J; Tafulo S; Dias L; Martins S; Fonseca I; Beirão I; Castro-Henriques A; Cabrita A
Transpl Int; 2017 Apr; 30(4):347-359. PubMed ID: 27717025
[TBL] [Abstract][Full Text] [Related]
14. Preformed C1q-binding Donor-specific Anti-HLA Antibodies and Graft Function After Kidney Transplantation.
Okabe Y; Noguchi H; Miyamoto K; Kaku K; Tsuchimoto A; Masutani K; Nakamura M
Transplant Proc; 2018 Dec; 50(10):3460-3466. PubMed ID: 30577221
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of low pre-transplant donor specific antibodies (DSA) in living donor kidney recipients with negative complement-dependent cytotoxicity crossmatches (CDCXM), and negative flow cytometry crossmatches (FLXM) - A single-center experience.
Olszowska-Zaremba N; Gozdowska J; Zagożdżon R
Transpl Immunol; 2022 Oct; 74():101672. PubMed ID: 35868613
[TBL] [Abstract][Full Text] [Related]
16. Association of C1q-fixing DSA with late graft failure in pediatric renal transplant recipients.
Fichtner A; Süsal C; Höcker B; Rieger S; Waldherr R; Westhoff JH; Sander A; Opelz G; Tönshoff B
Pediatr Nephrol; 2016 Jul; 31(7):1157-66. PubMed ID: 26928311
[TBL] [Abstract][Full Text] [Related]
17. Use of complement binding assays to assess the efficacy of antibody mediated rejection therapy and prediction of graft survival in kidney transplantation.
Ramon DS; Huang Y; Zhao L; Rendulic T; Park JM; Sung RS; Samaniego M
Hum Immunol; 2017 Feb; 78(2):57-63. PubMed ID: 27894836
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the C1q-Binding Ability and the IgG1-4 Subclass Profile of Preformed Anti-HLA Antibodies by Solid-Phase Assays.
Navas A; Molina J; Agüera ML; Guler I; Jurado A; Rodríguez-Benot A; Alonso C; Solana R
Front Immunol; 2019; 10():1712. PubMed ID: 31428086
[TBL] [Abstract][Full Text] [Related]
19. The role of complement-fixing donor-specific antibodies identified by a C1q assay after heart transplantation.
Farrero Torres M; Pando MJ; Luo C; Luikart H; Valantine H; Khush K
Clin Transplant; 2017 Nov; 31(11):. PubMed ID: 28940521
[TBL] [Abstract][Full Text] [Related]
20. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
Wu P; Jin J; Everly MJ; Lin C; Terasaki PI; Chen J
Clin Biochem; 2013 Oct; 46(15):1389-93. PubMed ID: 23726814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
